India’s pharmaceutical manufacturing industry is entering a delicate phase in its development. As uncertainty grows over its long-term access to the US market, the country is gaining improved access to other major overseas markets, says GlobalData, a leading intelligence and productivity platform. The US remains hugely important to Indian pharma, accounting for over 30% of […]